Search Results - Thakkinstian A
- Showing 1 - 1 results of 1
-
1
Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective by Bagepally BS, Chaikledkaew U, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book